University conducts study on pharmacy’s role in promotion of continence

Date:

Share post:

The University of the West of England (UWE) is conducting a survey to explore current practice in community pharmacy regarding the management of individuals who present with bladder and/or bowel incontinence.

Approximately one in five people experience bladder or bowel leakage and they often do not know those simple conservative strategies can make a difference.

A team from the UWE is conducting a study to understand the views on the Pharmacy Role In proMotion of continencE (PRIME); learn from current experiences; and explore what is feasible to develop, for improved bladder and bowel continence promotion.

The survey should take around 10-15 minutes to complete and should be completed by one member of staff working within the community pharmacy.

Ideally, this should be the person who knows most about the services and products available from the pharmacy for the management of continence. Answers to the survey will be confidential and anonymous.

The results of the survey will be disseminated through a variety of channels, for example through publication in scientific journals, conference presentations, and social media.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

Shadow Health Minister Preet Kaur Gill visits pharmacy in Staffordshire

Preet Kaur Gill, Shadow Minister for Primary Care and Public Health, has paid a recent visit to a...

Superdrug to halt single-use vape sales in UK, Ireland due to environmental concerns

British pharmacy chain Superdrug has announced plans to cease the sale of disposable vapes in all its UK...

Closure of temporary registers by 31 March 2024: GPhC

Pharmacists on the temporary register will be automatically removed on April 1, unless they have applied to rejoin the...

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...